FDA BRIEF: Week of May 22, 2017


FDA Commissioner Asks Staff for ‘More Forceful Steps’ to Stem the Opioid Crisis

By: Scott Gottlieb, M.D., Commissioner. @SGottliebFDA

Dr. Scott Gottlieb

Highest initial priority is reduce epidemic of opioid addiction; Establishing Opioid Steering Committee

  • Explore and develop additional FDA tools to answer following questions
  • ? Mandatory education for health care professionals: appropriate prescribing recommendations, identify abuse risk, treat addicted patients
  • ? Additional risk management to tailor prescription of opioid doses
  • ? Proper policy framework  for risk of abuse and misuse


Public Workshop – Cybersecurity of Medical Devices: A Regulatory Science Gap Analysis

Hosted by FDA, National Science Foundation (NSF) and Department of Homeland Security, Science and Technology (DHS, S&T)


  • Examine opportunities for FDA engagement with new and ongoing research
  • Catalyze collaboration among stakeholders to identify regulatory science challenges
  • Discuss innovative strategies to address those challenges
  • Encourage proactive development of analytical tools, processes, and best practices





Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s